TTrialPathMatch Me to Trials
← Back to trials
RecruitingArthroplasty, Replacement

SMR Stemless Reverse vs SMR Reverse Shoulder System

Eligible age

22+ yrs

Accepts

All genders

Locations

9 states

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

The SMR Stemless Reverse is intended for total, primary shoulder joint replacement by reducing pain and restoring shoulder articular mobility function. This is a prospective, multi-center, randomized, controlled trial to demonstrate non-inferiority of the SMR Stemless Reverse to the SMR Reverse Shoulder System. Patients with joint dysfunction who continue to experience significant symptoms despite an appropriate course of non-operative management are eligible. Patients will be considered enrolled into the study when an ICF has been signed, all inclusion criteria are met and no exclusion criteria are present including intraoperative exclusion criteria, and the patient is randomized into either the SMR Stemless Reverse (investigational) group, the SMR Reverse Shoulder System (control) group or is part of the roll-in population. Enrollment is expected to take approximately 24 months.

Sponsor: Limacorporate S.p.a

You may qualify if…

  • ✓ 1. Age ≥ 22 years of age
  • ✓ 2. Skeletally mature as evident by scapula and proximal humerus closure
  • ✓ 3. Candidate for primary total shoulder replacement in a grossly rotator cuff deficient joint with severe arthropathy (disabled shoulder), when clinical indications based on physical exam and medical history including one or more of the following:
  • ✓ 1. Arthritis with rotator cuff tear not reparable
  • ✓ 2. Irreparable rotator cuff tear
  • ✓ 3. Rotator cuff tear arthropathy
  • ✓ 4. Severe osteoarthritis and rotator cuff deficiency or stiff shoulder
  • ✓ 5. Significant glenoid or socket side bone deformed or loss

You may not qualify if…

  • ✕ 1. BMI \> 40 kg/m2
  • ✕ 2. Previous contralateral shoulder surgery within 3 months of enrollment or that requires active treatment (i.e. surgery or brace)
  • ✕ 3. Had surgery in the targeted shoulder within last 12 months of enrollment, except diagnostic arthroscopy without procedures
  • ✕ 4. Had surgery in lower limbs (such as hip or knee) within last 6 months of enrollment
  • ✕ 5. Corticosteroid injections in the ipsilateral shoulder within 3 months of enrollment
  • ✕ 6. Complete deltoid muscle insufficiency
  • ✕ 7. Glenoid retroversion great than 25 degrees based off a 2D axial CT scan
  • ✕ 8. History of/or signs and/or symptoms of local or systemic infection including but not limited to septicemia; osteomyelitis

Where it's recruiting

California

Los Angeles

Colorado

Denver

Florida

Boca Raton · Orlando · Tampa

Illinois

Chicago

Indiana

Fishers

New York

East Syracuse

Pennsylvania

Philadelphia · Sayre

Texas

San Antonio

Source: ClinicalTrials.gov · NCT04697004 · last updated 2026-10-28

SMR Stemless Reverse vs SMR Reverse Shoulder System · TrialPath